Free Shipping on orders over $75

Medical Studies

Anxiety

Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives 

Stomach and bone cancer

Pre-Clinical Study Suggests CBG Is More Effective Than CBGA on Stomach and Bone Cancers

Prostate, breast, and bladder

CBG: A New(er) Option for Cancer Treatment?

Colorectal cancers

Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.


Pain Relief

Cannabinoids in the management of difficult to treat pain


Inflammation

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid


Inflammatory Bowel Disease

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.


Neuroprotective potential

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid.


Oral bacteria

Comparison of Efficacy of Cannabinoids versus Commercial Oral Care Products in Reducing Bacterial Content from Dental Plaque: A Preliminary Observation.


Parkinson’s Disease

Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease.


Huntington’s Disease

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease


Motor Disorders

Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …


Antibiotics

Uncovering the Hidden Antibiotic Potential of Cannabis.

Search